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Summary The aim of this paper was to provide epidemiological evidence to support the notion that cervical
intraepithelial neoplasia (CIN) without human papillomavirus (HPV) is a true entity. If a diagnosis of HPV-
negative cervical neoplasia is erroneous, one would not expect there to be any differences in risk factors
between HPV-positive and HPV-negative patients. Patients at a gynaecological outpatient clinic of a university
hospital [a total of 265 consecutive women with dyskaryotic cervical smears who were subsequently diagnosed
with CIN I (n =37), CIN II (n =48) or CIN III (n = 180)] completed a structured questionnaire regarding
smoking habits and sexual history. Analysis of an endocervical swab for Chlamydia trachomatis, analysis of a
cervical scrape for HPV, and morphological examination of cervical biopsy specimens were also performed.
HPV was found in 205 (77.4%) out of the 265 women. Univariate analysis showed that current age (P=0.02),
current smoking behaviour (P =0.002) and the number of sexual partners (P =0.02) were significantly
associated with the presence of HPV. Age at first sexual intercourse, a past history of venereal disease or
genital warts, and current infection with Chiamydia trachomatis were not associated with the presence of HPV.
Using multivariate logistic regression analysis, the number of sexual partners and current smoking behaviour
showed an independent significant association with HPV. HPV-negative and HPV-positive CIN patients differ
with respect to the risk factors for HPV. These findings suggest that HPV-negative CIN is a separate true
entity.
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Cervical intraepithelial neoplasia (CIN) is a morphologically
defined lesion associated with the development of cervical
carcinoma. In the conventional morphogenetic model CIN is
separated into three grades according to the degree ofcellular
atypia and disturbance of the epithelial architecture (Richart,
1973). The infection with human papillomavirus (HPV) is
strongly associated with cervical neoplasia. HPV shows
considerable genetic heterogeneity (De Villiers, 1989), and a
great diversity of HPV types is found in CIN (Van den Brule
et al., 1990; Lungu et al., 1992; Bergeron et al., 1992). Known
risk factors for cervical HPV infection are a comparatively
young age and an increased lifetime number of sexual
partners (Schiffman, 1994; Woodman, 1994). Smoking has
also been identified as a risk factor (Burger et al., 1993).
Several investigators are of the opinion that all cervical
neoplasms are caused by HPV. At the 13th International
Papillomavirus Conference in October 1994 in Amsterdam
Mufioz et al. (Franco, 1994) revised a previously reported
85% detection rate of HPV in cervical carcinomas to 95%.
Franco (1994) reported that this figure was still being
scrutinised by the authors and it was likely that additional
HPV-positive samples would be declared, raising the
detection rate to very close to 100%. Such a result would
be at odds with previous observations that HPV-negative and
HPV-positive patients with squamous cell cancer ofthe cervix
differ with respect to age and prognosis (Higgins et al., 1991;
Riou et al., 1990). Opinions regarding the prevalence of HPV
in CIN are fairly consistent. Schiffman (1994) mentioned that
in their studies the prevalence of HPV in definite cases of
CIN approached 100%. In the past they had reported a
lower prevalence in low-grade CIN because they could not
test for the full spectrum of HPV types and they had not yet
minimised cytopathological misclassification of low-grade
CIN. False HPV-negative neoplasia specimens could in fact
represent instances of sampling error or insufficient test
sensitivity, or cases caused by unknown HPV types that
could have been missed by current detection systems.
In the study presented here we compared HPV-positive
and HPV-negative CIN patients with regard to the risk
factors for HPV infection. These groups are not expected to
differ with regard to age, sexual variables and smoking if the
diagnosis of HPV-negative CIN is in fact erroneous. The




Patients were recruited from the outpatient clinic of the
Department of Gynaecology, University Hospital Groningen.
They were either referred by their general practitioner, owing
to an abnormal cervical cytology report, or the cervical
cytological abnormality was discovered during gynaecological
examination. Patients were eligible for participation in the
study if they had two mildly or moderately dyskaryotic
cervical smears or one severely dyskaryotic smear. These
cytological criteria for eligibility correspond with the grounds
for colposcopy as agreed by cytopathologists and gynaecol-
ogists in the Netherlands. In the case of mild or moderate
dyskaryosis the interval between the two abnormal smears
was a maximum of 1 year. Patients were not eligible if they
had previously undergone a colposcopic examination because
of an abnormal cytology report or if their cervical smear was
taken during pregnancy. All the patients were invited to the
outpatient clinic to obtain data using a structured ques-
tionnaire and to have a cervical scrape taken for HPV
analysis and an endocervical swab for Chlamydia trachomatis
analysis. During the 5 year period from 1 September 1988 to
1 September 1993, 343 consecutive patients were eligible for
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participation in the study. Twenty-three patients were
excluded for the following reasons: two patients did not
want to be involved in the study, two patients had insufficient
command of Dutch or English, four patients were pregnant
at the time of colposcopy and 15 patients were not treated in
accordance with the study protocol (i.e. no cervical scrape for
HPV analysis, or no biopsy, or no treatment when the biopsy
disclosed cervical intraepithelial neoplasia). Finally, a benign
change or (micro)invasive carcinoma was histologically found
in 41 and 14 patients respectively. Therefore, 265 newly
diagnosed patients with CIN were included in the study.
Some of these patients were also included in previous studies
on HPV and CIN (Burger et al., 1993, 1995).
Questionnaire
Using a structured questionnaire we asked the women to
state the mean number of cigarettes they were currently
smoking per day, their age at first sexual intercourse
(sexarche), their lifetime number of sexual partners and
whether they had ever had a sexually transmitted disease or
genital warts. All the women were told beforehand that the
questionnaire comprised some intimate questions and that
they were not obliged to answer.
Microbiological analyses
Firstly, an endocervical swab was taken for Chlamydia
trachomatis analysis. Within 4 h of collection this specimen
was inoculated on cycloheximide-treated McCoy cell mono-
layers on coverslips, as described by Ripa and MArdh (1977).
Detection of Chlamydia trachomatis inclusions was performed
after 48 h using fluorescein-conjugated monoclonal antibo-
dies (MikroTrak Culture Confirmation, Syva, Palo Alto, CA,
USA).
Secondly, after the swab for Chlamydia trachomatis culture
had been taken the cervix was scraped with the blunt and
pointed end of a wooden cervical spatula and with an
endocervical brush. The scraped cells were suspended in 5 ml
phosphate-buffered saline, pH 7.2, supplemented by merthio-
late 1:10 000 v/v. The cell suspension was sent to the
laboratory and processed the following morning. The
samples were analysed for the presence of HPV with the
use of a general primer-mediated polymerase chain reaction
(Snijders et al., 1990) and type-specific primer-mediated
polymerase chain reactions for the presence of HPV types
6, 11, 16, 18, 31 and 33 separately (Melchers et al., 1989;
Claas et al., 1989). If the general primer-mediated reaction
was positive but the reactions for types 6, 11, 16, 18, 31 and
33 were negative, the type remained unknown. The
laboratory staff were unaware of the histological reports.
Morphological examination
Four weeks after the cervix had been scraped we took
representative colposcopically directed biopsy samples of
atypical epithelium. If CIN of any grade was diagnosed we
subsequently excised the whole transformation zone by loop
electrosection or cold knife conisation. Diathermic loop
excision was used if the squamocolumnar junction could be
visualised entirely and did not extend up into the canal for
more than 5 mm from the anatomical os externum. The
details of the technique have been described previously
(Burger and Hollema, 1993).
Cervical neoplasia was diagnosed and graded according to
the criteria of the World Health Organization (Poulsen et al.,
1975). The cervical neoplasia was classified according to the
most severe lesion found by histological examination.
Statistical analysis
To test for a significant difference between 2 and >2 groups
of patients with regard to quantitative variables we used the
Mann-Whitney U-test and the Kruskal-Wallis test respec-
tively. To test for a significant difference between groups with
regard to a qualitative variable, we used the x2 test. These
non-parametric tests were performed using the SYSTAT
software package (Wilkinson, 1990). The x2 test for trend and
the logistic regression analysis were performed using the
EGRET software package (EGRET, 1992). To assess the
correlation between two variables with a continuous scale we
calculated Spearman's rank correlation coefficient using
SYSTAT. The 95% confidence interval of this coefficient
was calculated with the use of the CIA software package
(Gardner et al., 1991). P-values of less than 0.05 were
considered to be significant.
Results
The HPV types and the histological diagnoses
Table I shows the HPV types detected in relation to the
different histological diagnoses. HPV was found in 18 (47%)
out of the 37 patients with CIN I, in 33 (69%) out of 48
patients with CIN II and in 154 (86%) out of the 180 patients
with CIN III. Thus the prevalence of HPV increased with the
severity of the neoplastic lesion (X2=26.20, d.f. = 1, P<0.001;
test for trend).
The median age of the patients was 35.0 years
(interquartile range 29-39 years). No difference was found
between the three groups of histological diagnoses with
regard to age distribution (2 = 1.76, d.f.=2, P=0.41;
Kruskal-Wallis test).
Determinants for the presence of HPV
Table II shows the results of the comparison between HPV-
positive (all types) and HPV-negative patients with regard to
the possible determinants. The group ofHPV-positive women
differed significantly from the group of women without HPV
with respect to current age, the lifetime number of sexual
partners and the proportion of smokers. The differences with
regard to the median value of age and the lifetime number of
sexual partners were small: 2 years and one partner
respectively. In the smokers the number of cigarettes smoked
per day did not differ between the groups (P= 1.00; Mann-
Whitney U-test). No relation was found between the presence
of HPV and age at first sexual intercourse, a past history of
venereal disease, a past history of genital warts and current
infection with Chlamydia trachomatis.
We used 2 x k-table analysis and logistic regression to
appraise the relations between the presence of HPV and
current age, smoking behaviour and the lifetime number of
sexual partners. Table III shows the results of the analysis.
The proportion of women with HPV decreased significantly
Table I The HPV types in relation to the CIN grade
HPV type (s) CIN I CIN II CIN III Totals
No HPV 19 15 26 60
6/11 1 1
6/11, 16 1 1 2
6/11, 16, 31 1 1
16 4 11 93 108
16, 18 1 2 3 6
16, 31 3 3
16, 33 1 1
18 5 3 11 19
18, 31 1 1
18, 31, 33 1 1
18, 33 2 2
31 5 13 18
31, 33 1 1 2
33 1 8 9
Unknown type 5 8 18 31
Totals 37 48 180 265as the current age increased (2=6.59, d.f. = 1, P= 0.01; test
for trend). Compared with women under 30 years of age, the
odds ratio decreased to 0.35 for women who were 40 years or
older. Each year of life conferred a 4% decrease in risk (odds
ratio 0.96 with 0.92 and 1.00 as the limits of the 95%
confidence interval) when age was analysed as a continuous
variable.
The proportion of women with HPV increased signifi-
cantly as the number of cigarettes smoked a day increased
(2 = 10.31, d.f. = 1, P=0.001; test for trend). Compared with
women who did not smoke the point estimate of the odds
ratio increased to 3.79 in women who smoked more than 20
cigarettes a day. Each cigarette produced a 5% increase in
the risk for HPV when the number of cigarettes a day was
analysed as a continuous variable.
In the logistic regression analysis age at diagnosis and the
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number of cigarettes smoked per day could be treated as
continuous variables. By contrasting likelihood values it
became evident that the descriptive power of the logistic
models did not change if these factors were converted to
categorical variables. However, treating the lifetime number
of sexual partners as a continuous variable obscured the
predictive information it contained. The point estimate of the
proportion of HPV-positive women among those with one
partner and those with two partners in their lifetime was 23/
39 (60.0%) and 18/27 (66.7%) respectively. At the point of
three partners or more the proportion of HPV-positive
women levelled off. The point estimate of the proportion of
HPV-positive women who had had >3 partners was 156/189
(82.5%). Therefore, in the logistic models the lifetime number
of sexual partners was treated as a categorical variable with
three classes (1, 2 and >3). Compared with women with one
Table II Distribution of selected determinants in CIN patients according to the presence or absence of HPV (all types)
HPV
Present Absent
Factor (n=205) (n=60) P-value
Age (years)
Median 34 36 0.02a
Interquartile range 29-38 32-41
Sexarche (years)
Median 17 17.5 0.27a
Interquartile range 16- 19 16-19
Lifetime number of partners
Median 4 3 0.02a
Interquartile range 3-10 1-10
Past hisory of venereal disease
Number (%) 37 (18.0%) 9 (15.0%) 0.72b
Past history of genital warts
Number (%), 23 (11.2%) 4 (6.7%) 0.43b
Current smoking
Number (%) 145 (70.7%) 29 (48.3%) 0.002b
Chlamydia trachomatis present
Number (%) 3 (1.5) 1 (1.7)
aMann-Whitney U-test. bX2 test for two groups with Yates' correction.
Table IHI Odds ratios for HPV infection by current age, number of cigarettes smoked per day and lifetime number of sexual partners in
patients with CIN.
Odds ratio (95% confidence interval)
for the HPV infection
Proportion with
Variable HPV infection (%) Crude Adjustead
Age (years)
K29 60/71 (84.5) 1 (reference) 1 (reference)
30-34 48/59 (81.4) 0.80 (0.32-2.00) 0.80 (0.31 -2.10)
35-39 59/77 (76.6) 0.60 (0.26-1.38) 0.71 (0.30-1.68)
,40 38/58 (65.5) 0.35 (0.15-0.81) 0.45 (0.18-1.06)




0 60/91 (65.9) 1 (reference) 1 (reference)
1-10 40/50 (80.0) 2.07 (0.91-4.68) 1.71 (0.73-4.02)
11-20 61/74 (82.4) 2.42 (1.16-5.08) 1.88 (0.85-4.17)
>21 44/50 (88.0) 3.79 (1.45-9.86) 3.11 (1.16-8.29)
Trend per cigarette 1.05 (1.01-1.08) 1.04 (1.01 -1.07)
(P =0.003) (P =0.02)
Lifetime number of
sexual partnersb
1 23/39 (60.0) 1 (reference) 1 (reference)
2 18/27 (66.7) 1.39 (0.50-3.87) 1.23 (0.43-3.50)
>3 156/189 (82.5) 3.29 (1.57-6.89) 2.58 (1.19-5.62)
Trend per category 1.85 (1.29-2.66) 1.64 (1.13-2.40)
(P<0.001) (P=0.01)
aThe estimates for each of the three factors are adjusted for the two other factors through logistic regression. bData missing for ten cases.Epidemiological evidence of HPV-negative CIN
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sexual partner in their lifetime the point estimate of the odds
ratio increased significantly to 3.29 in women with three or
more partners.
We analysed whether smoking behaviour, age at diagnosis
and the lifetime number of sexual partners are interrelated. In
the group of current smokers the median age was
significantly lower than in the group of non-smokers: 32.5
(interquartile range 29-38) years and 35.0 (interquartile
range 31.5-41) years respectively (P = 0.001, Mann-Whitney
U-test). In the groups of smokers and non-smokers the
median lifetime number of sexual partners was four
(interquartile range 3-10) and four (interquartile range 2-
10) respectively. Although the median values are similar,
statistically the smokers have had more partners (P=0.05,
Mann-Whitney U-test). Spearman's rank correlation coeffi-
cient between the current age and the lifetime number of
sexual partners was -0.21 with a 95% confidence interval
from -0.32 to -0.09. Therefore, there was a significantly
negative relation between current age and the lifetime number
of sexual partners. We conclude that smoking behaviour,
current age and the lifetime number of sexual partners are
interrelated.
We subsequently performed a multivariate logistic
regression analysis. Table III shows that the number of
cigarettes smoked per day and the lifetime number of sexual
partners are independent significant determinants for the
presence of HPV. The inverse association between age and
the presence of HPV disappeared after adjustment had been
made for smoking and the lifetime number of partners.
Finally, we analysed whether the three variables that we
had identified were also associated with HPV in women with
CIN II or CIN III. For this purpose we excluded patients
with CIN I from the following analysis. The median age
(with limits of the interquartile interval) was 35 (29.5-38)
years and 36 (32-40) years in the HPV-positive and HPV-
negative patients with CIN II-III respectively (P= 0.12;
Mann-Whitney U-test). The median lifetime number (with
limits of the interquartile range) of sexual partners was 4 (3-
10) and 3 (1-8.5) in the HPV-positive and HPV-negative
patients with CIN II-III respectively (P=0.04; Mann-
Whitney U-test). The proportion of smokers was 132/187
(70.6%) and 22/41 (53.7%) in the HPV-positive and HPV-
negative patients with CIN II-III respectively (X2 =3.66,
d.f. = 1, P=0.06; X2-test with Yates' correction). We conclude
that the results remain largely unaltered when the analysis
was restricted to women with CIN II or CIN III.
Discussion
We found that HPV-positive and HPV-negative CIN patients
differed significantly with respect to their smoking behaviour
and the lifetime number of sexual partners. We also
performed the analysis on patients who were diagnosed with
CIN II or CIN III because it has been demonstrated that
benign infectious or reactive changes are difficult to
discriminate from CIN I (Ismail et al., 1989). Most studies
have found that CIN II and CIN III are similar with regard
to their associated HPV types and DNA ploidy (Wright and
Kurman, 1994). Practically no differences were found
compared with the analysis including all women. As women
with CIN II and CIN III constituted 228 (86%) of the 265
patients studied, we did no expect that the results would
differ substantially. Our findings strongly favour the existence
of HPV-negative cervical neoplasia and it is noteworthy that
the determinants of the occurrence of HPV in patients with
cervical neoplasia show striking similarities to those in other
(non-oncological) populations.
Our study group included a comparatively high proportion
of women with CIN II or CIN III. We applied stringent
cytological ground for entry into the study group. All of the
patients had either two mildly or moderately dyskaryotic
cervical smears or one severely dyskaryotic smear. In
addition, we studied the complete transformation zone
because we performed loop electrosection or cold knife
conisation. In a previous study we demonstrated that the
biopsy diagnosis tends to underestimate the true severity of
the disease (Burger and Hollema, 1993).
We found HPV (all types) in 69% and 86% of the patients
with CIN II and CIN III, respectively. A limited number of
other investigators have reported higher frequencies and
some claim that all high-grade CIN lesions harbour HPV
(reviewed by Walboomers et al., 1994). Estimates of the
prevalence of genital HPV infection depend on the
population investigated and the HPV assay used (Guerrero
et al., 1992; Schiffman, 1992). Quality assurance programmes
have indicated that PCR test interpretation should be done
with great care in order to avoid false-positive (and false-
negative) assessments (Quint et al., 1995). The probability of
detecting HPV is increased if there is ample clinical material
available. It has been demonstrated that the proportion of
HPV-positive women increases with increasing quantities of
cellular DNA in cytological samples (Woodman, 1994). In
our study the same set of primers was used throughout and
the laboratory staff were unaware of the histological reports.
After adjustment for age and the lifetime number of sexual
partners we found a significant independent effect of smoking
on the occurrence of HPV. This finding is in accordance with
our previous report regarding a significant dose-response
relation between the number of cigarettes smoked per day
and the occurrence ofoncogenic HPV in the cervix ofwomen
with cytological abnormalities (Burger et al., 1993). An effect
of smoking on the occurrence of HPV, adjusted for the
number of sexual partners and age, has also been
demonstrated in a case-control study by Kataja et al. (1993).
After adjustment for current smoking behaviour and age
we found a significant relation between the lifetime number
of sexual partners and the presence of HPV. In the linear
logistic model the predictive information from the lifetime
number of sexual partners was optimised by using three
categories: 1, 2 and >3. If a woman had had three partners,
a further increase in the number of partners did not affect the
probability that she would be diagnosed with a cervical HPV
infection. A relation between the lifetime number of sexual
partners and HPV infection, adjusted for smoking behaviour
and age, has also been demonstrated by Kataja et al. (1993)
and Bauer et al. (1993). We emphasise that adjustment
should be made for smoking if the impact of sexual
behaviour on the occurrence of the HPV infection is
studied. This follows from the fact that we demonstrated
an association between the lifetime number of male sexual
partners and smoking behaviour, as has also been done in a
study on women attending a university health service (Ley et
al., 1991) and on women attending a sexually transmitted
diseases clinic (Willmott, 1992).
It is commonly assumed that a comparatively increased
number of sexual partners indicates the involvement of a
sexually transmittable agent. However, there are also several
arguments for non-sexual transmission routes (Woodman,
1994). Our inability to demonstrate a relation between HPV
infection and sexually transmitted diseases contributes to the
doubts about the importance of sexual transmission. We
could not detect an association between the occurrence of
HPV and a past history of venereal disease, a past history of
genital warts (which are associated with the 'benign' HPV
types of 6 and 11) or current cervical Chlamydia trachomatis
infection. Owing to the fact that several sexually transmitted
diseases frequently occur together one would expect to find
an association between the presence of HPV and sexually
transmittable agents. Other investigators did not find an
association between the occurrence of HPV and Chlamydia
trachomatis in women attending an STD clinic (Claas et al.,
1992).
In the univariate analysis we found an inverse relation
between the occurrence of HPV and age. This age
dependency of the HPV infection has been reported in
groups of healthy women (De Villiers et al., 1992; Melkert et
al., 1993) and in cervical carcinoma patients (Higgins et al.,
1991). All the studies showed that the younger the patient,
the higher the chance of detecting HPV. These findingsEpadnWogca evidance of HUV-negave Ca
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indicate that age should also be considered as a confounder
in comparative studies. The prevalence of HPV in healthy
young females is high. Dutch investigators, who used a
general primer-mediated polymerase chain reaction, detected
cervical HPV infection in 25% of the women aged 20-25
years who underwent a routine check-up by their general
practitioner because they were using oral contraceptives
(Melkert et al., 1993). This figure represents the result of a
single determination and repeated determinations at given
time intervals are known to result in much higher figures
(Schneider and Koutsky, 1992). The combined epidemiologi-
cal evidence is compatible with the notion that the majority
of young people will acquire a genital HPV infection, either
by a sexual or non-sexual route. Apparently, most HPV
infections resolve spontaneously with increasing age. A small
percentage of women will suffer from persistent infections
with neoplasia as a possible consequence if the HIPV type
concerned is oncogenic. Nevertheless, our study provides
strong arguments in favour ofa non-HIPV-related aetiological
route for cervical neoplasia.
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